A detailed history of National Asset Management, Inc. transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, National Asset Management, Inc. holds 11,412 shares of AUPH stock, worth $102,479. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,412
Previous 14,746 22.61%
Holding current value
$102,479
Previous $84,000 1.19%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Dec 13, 2024

SELL
$5.32 - $7.33 $17,736 - $24,438
-3,334 Reduced 22.61%
11,412 $83,000
Q2 2024

Aug 19, 2024

BUY
$4.81 - $5.78 $70,928 - $85,231
14,746 New
14,746 $84,000

Others Institutions Holding AUPH

About Aurinia Pharmaceuticals Inc.


  • Ticker AUPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,892,000
  • Market Cap $1.27B
  • Description
  • Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...
More about AUPH
Track This Portfolio

Track National Asset Management, Inc. Portfolio

Follow National Asset Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of National Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on National Asset Management, Inc. with notifications on news.